NovoCure Limited — Cash Flow (NASDAQ:NVCR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 99.15 M82.76 M30.79 M73.34 M26.37 M49.03 M 49.03 M Cash from investing activities 472.85 M144.83 M139.96 M184.15 M140.24 M437.28 M 437.28 M Cash from financing activities 440.21 M25.7 M15.49 M15.79 M90.31 M451.34 M 451.34 M Free cash flow 84.18 M58.59 M9.43 M46.24 M-16.49 M22.38 M 22.38 M

News

NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates

NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript

Novocure Ltd earnings beat by $0.19, revenue topped estimates

Netflix and Palantir among market cap stock movers on Wednesday

Novocure earnings up next: Pancreatic cancer launch in focus

Oracle and Netflix among market cap stock movers on Wednesday

Novocure stock jumps after Medicare billing restored

Will NovoCure (NVCR) Report Negative Earnings Next Week? What You Should Know

Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer

NovoCure: FDA Approval For PC Unlocked With TTFields Expansion Opportunity Approaching

CSCO, PLTR among market cap stock movers on Thursday

Cisco and Micron among market cap stock movers on Thursday